Slovak Republic vs Türkiye: Pharmaceutical consumption

Slovak Republic
284.4 Defined daily dose per 1 000 inhabitants per day
in 2024
Türkiye
548.9 Defined daily dose per 1 000 inhabitants per day
in 2024
Slovak Republic rank
3rd
Türkiye rank
1st

Pharmaceutical consumption over time

  • Slovak Republic
  • Türkiye
100200300400500199520092024

How they compare

Türkiye currently reports 548.9 Defined daily dose per 1 000 inhabitants per day against 284.4 Defined daily dose per 1 000 inhabitants per day in Slovak Republic, a difference of 264.5 Defined daily dose per 1 000 inhabitants per day.

That makes Türkiye's figure about 1.9 times Slovak Republic's.

The two have swapped places 1 time across 17 shared years of data; in 2008 it was Slovak Republic ahead.

Slovak Republic ranks 3rd and Türkiye ranks 1st of 3 groups.

Across the 3 decades both report, Slovak Republic averaged higher in 2 and Türkiye in 1.

Head to head by decade

Decade Slovak Republic Türkiye Difference Ahead
2000s 275.6 Defined daily dose per 1 000 inhabitants per day 122.3 Defined daily dose per 1 000 inhabitants per day 153.3 Defined daily dose per 1 000 inhabitants per day Slovak Republic
2010s 298.45 Defined daily dose per 1 000 inhabitants per day 266.57 Defined daily dose per 1 000 inhabitants per day 31.88 Defined daily dose per 1 000 inhabitants per day Slovak Republic
2020s 313.42 Defined daily dose per 1 000 inhabitants per day 487.82 Defined daily dose per 1 000 inhabitants per day 174.4 Defined daily dose per 1 000 inhabitants per day Türkiye

Averages of every year both report within each decade.

Frequently asked questions

Which has higher pharmaceutical consumption, Slovak Republic or Türkiye?
Türkiye, at 548.9 Defined daily dose per 1 000 inhabitants per day against 284.4 Defined daily dose per 1 000 inhabitants per day in Slovak Republic as of 2024.
What is the difference in pharmaceutical consumption between Slovak Republic and Türkiye?
264.5 Defined daily dose per 1 000 inhabitants per day, with Türkiye ahead.
How many years of comparable data are there for Slovak Republic and Türkiye?
17 years are reported by both, from 2008 to 2024.
How do Slovak Republic and Türkiye rank globally for pharmaceutical consumption?
Slovak Republic ranks 3rd and Türkiye ranks 1st of 3 groups.
Where does this data come from?
Organisation for Economic Co-operation and Development, published as Pharmaceutical consumption. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Slovak Republic vs Türkiye: Pharmaceutical consumption. Statizoid, drawing on Organisation for Economic Co-operation and Development. Retrieved 10 November 2026, from https://health.statizoid.com/compare/pharmaceutical-consumption/slovak-republic-2/turkiye-2/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under OECD Terms and Conditions (attribution required); please keep the attribution.

<a href="https://health.statizoid.com/compare/pharmaceutical-consumption/slovak-republic-2/turkiye-2/">Slovak Republic vs Türkiye: Pharmaceutical consumption</a> — Statizoid

About this data

Indicator
Pharmaceutical consumption
Unit
Defined daily dose per 1 000 inhabitants per day
Source
Organisation for Economic Co-operation and Development
Licence
OECD Terms and Conditions (attribution required)
Coverage
31 places, 708 data points, 1980–2025
Last refreshed

Total pharmaceutical consumption according to the Anatomical Therapeutic Chemical (ATC) classification/Defined Daily Dose (DDD) system, created by the WHO Collaborating Centre for Drug Statistics Methodology. The unit of measurement is Defined Daily Dose (DDD), defined as the assumed average maintenance dose per day for a drug used on its main indication in adults. The Anatomical Therapeutic Chemical classification system divides drugs into different groups according to the organ system on which they act and/or therapeutical, pharmacological and chemical characteristics. The main principles for the classification of medicinal substances according to the ATC is presented in the publication “Guidelines for ATC classification and DDD assignment”, WHO Collaborating Centre for Drug Statistics Methodology, Oslo. The publication “ATC Index with DDDs” lists all assigned ATC codes and DDD values. Both these publications are updated annually. The ATC codes are based on the 2026 version of the ATC Index. All alterations implemented from January 2026 are available on the WHO Collaborating Centre for Drug Statistics Methodology website at https://www.whocc.no/lists_of__temporary_atc_ddds_and_alterations/. Data should reflect, where possible, the total consumption for each pharmaceutical drug category, i.e. including consumption in hospitals. Please refer to the Sources and Methods for detailed country-specific information.